The draft clinical policy related to the use of thrombolytics for the management of acute ischemic stroke is in the review stage of ACEP clinical policy development. Comments on the draft are being sought by the ACEP Clinical Policies Committee. Please focus your comments on the clinical content of the document, and not copyediting. Document your comments in the format requested, making note of additional evidence as appropriate. All comments will be carefully reviewed by the Clinical Policies Committee and used to further refine and enhance the draft when evidence supports the changes. Individual reviewer names will not be used in the final document. Comments do not imply endorsement of the document and will be stated as such in the final document.
Please provide comments by June 10, 2024.
For questions, please contact Travis Schulz, MLS, AHIP via email. Thank you for providing comments.
